Position in GPCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$254,399,664
+$48,110,991 QoQ
Shares Held
4,740,072
+10.8% QoQ
Ownership
6.65%
of shares outstanding
% of Portfolio
3.87%
of 13F equity value
Holder Rank
#5
of 191 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. GPCR ranks #2 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
9,341,151 | $359,914,548 | |
| 2 | GPCR |
Structure Therapeutics Inc.
This page
|
4,740,072 | $254,399,664 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,959,000 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
825,000 | $248,349,750 | |
| 5 | MANE |
Veradermics, Inc
|
2,000,000 | $245,880,000 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,666,768 | $230,786,377 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $193,319,289 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,307,481 | $189,254,062 |
All Filings in GPCR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,399,664 | 4,740,072 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $206,288,673 | 4,279,848 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $285,974,438 | 4,111,782 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $118,042,708 | 4,215,811 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $106,477,438 | 5,133,917 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $70,971,000 | 4,100,000 | Shares | Sole | 2025-05-15 | |
| 2025-01-06 | $247,500,000 | 9,000,000 | Shares | Sole | 2025-01-13 | |
| 2024-12-31 | $75,936,000 | 2,800,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,568,096 | 1,220,508 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $37,306,500 | 950,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,720,271 | 40,137 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,228,000 | 300,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $96,554,300 | 1,915,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $110,026,727 | 2,646,782 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $62,966,943 | 2,646,782 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||